Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Phase I”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT06717269
What this trial is testing

A Single and Multiple Ascending Doses, Relative Bioavailability, Food Effect, and Drug-Drug Interaction Study of NX-5948 in Healthy Volunteers

Who this might be right for
Healthy Volunteer
Nurix Therapeutics, Inc. 223
Early research (Phase 1)Study completedNCT02804568
What this trial is testing

Safety Study in Adults With Schizophrenia

Who this might be right for
Schizophrenia
Alkermes, Inc. 42
Early research (Phase 1)Study completedNCT00960791
What this trial is testing

Study to Assess the Absorption, Distribution, Metabolism and Excretion of AZD1656 in Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Type II Diabetes Mellitus
AstraZeneca 6
Early research (Phase 1)Study completedNCT01176474
What this trial is testing

Vaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-1 Antibody Nivolumab or Ipilimumab With Nivolumab For Patients With Resected Stages IIIC/ IV Melanoma

Who this might be right for
Melanoma (Skin)
H. Lee Moffitt Cancer Center and Research Institute 73
Testing effectiveness (Phase 2)Study completedNCT01067820
What this trial is testing

ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation

Who this might be right for
Coronary Artery Disease
Resverlogix Corp 324
Early research (Phase 1)Study completedNCT00001020
What this trial is testing

A Phase I Study of the Safety and Immunogenicity of rgp120/HIV-1IIIB Vaccine in Healthy Adult Subjects (NOTE: Study Extended ONLY for Subjects Who Have Previously Received rgp120/HIV-1IIIB or rgp120/HIV-1MN on VEU 006 or VEU 006 Rollover Study)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 28
Testing effectiveness (Phase 2)UnknownNCT00655460
What this trial is testing

Improving Blood Glucose Control With a Computerized Decision Support Tool: Phase 1

Who this might be right for
Critically IllHyperglycemia
Intermountain Health Care, Inc. 200
Early research (Phase 1)Study completedNCT01435382
What this trial is testing

A Pharmacokinetic and Pharmacodynamic Study of PF-04950615 (RN316) in Subjects With Hypercholesterolemia

Who this might be right for
HypercholesterolemiaDyslipidemiasHyperlipidemias+2 more
Pfizer 49
Early research (Phase 1)Study completedNCT00902824
What this trial is testing

Safety and Immunogenicity of TBC-M4, a MVA HIV Vaccine Alone or in a Prime-Boost Regimen With ADVAX DNA HIV Vaccine

Who this might be right for
HIV Infections
International AIDS Vaccine Initiative 32
Early research (Phase 1)Ended earlyNCT00972023
What this trial is testing

DHEA in Treating Women Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer

Who this might be right for
Breast Cancer
Barbara Ann Karmanos Cancer Institute 1
Early research (Phase 1)Temporarily pausedNCT06802523
What this trial is testing

Testing the Combination of Targeted Radiotherapy With Anti-Cancer Drugs, Venetoclax and ASTX-727, to Improve Outcomes for Adults With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
National Cancer Institute (NCI) 53
Early research (Phase 1)Not Yet RecruitingNCT05474859
What this trial is testing

Subjects With Advanced or Metastatic Solid Tumor Malignancies

Who this might be right for
Metastatic Solid TumorAdvanced Solid Tumor
Xenthera, Inc. 30
Early research (Phase 1)Study completedNCT03894579
What this trial is testing

Autologous Natural Killer Cells in Subjects With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
NKGen Biotech, Inc. 9
Early research (Phase 1)Study completedNCT00374179
What this trial is testing

CT-322 in Treating Patients With Advanced Solid Tumors and Non-Hodgkin's Lymphoma

Who this might be right for
Cancer
Adnexus, A Bristol-Myers Squibb R&D Company 40
Testing effectiveness (Phase 2)Looking for participantsNCT05423262
What this trial is testing

TRK-950 in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorMelanoma
Toray Industries, Inc 49
Early research (Phase 1)UnknownNCT05041088
What this trial is testing

Omega 3 Oil: Aging-Related Cognitive Decline

Who this might be right for
Aging Related Cognitive Decline
Neurological Associates of West Los Angeles 40
Early research (Phase 1)Ended earlyNCT06523803
What this trial is testing

ZW171 in Participants With Advanced or Metastatic Mesothelin-expressing Cancers

Who this might be right for
Mesothelin-expressing Advanced Cancers
Zymeworks BC Inc. 32
Early research (Phase 1)Study completedNCT06567327
What this trial is testing

Learn How the Study Medicine Danuglipron is Taken Up Into the Blood and If Danuglipron Changes How the Body Processes Other Study Medicines (Atorvastatin and Rosuvastatin) in Healthy Adults Who Are Overweight or Obese

Who this might be right for
Obesity
Pfizer 82
Early research (Phase 1)Study completedNCT00059761
What this trial is testing

Chemotherapy Combined With Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 36
Early research (Phase 1)Looking for participantsNCT06991361
What this trial is testing

Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic GVHD

Who this might be right for
Graft Versus Host Disease (cGvHD)
Leslie Kean 21
Next Page